Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05510050 · ClinicalTrials.gov registry record · NA
Comparison Study of Manapol and DaltonMax on Immune Function, Microbiome, and Related Variables in Men and Women
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05510050: Completed NA study, sponsored by University of Memphis.
NCT05510050 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05510050, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The present study will compare the effect of Manapol to DaltonMax on select measures of health. Currently, both ingredients are sold both as a stand-alone dietary supplement and as an active ingredient within various multi-nutrient products. Immune function will be assessed using blood samples to determine white blood cell counts and distributions, and cytokine levels with/without lipopolysaccharide (LPS) challenge. Additionally, effects specific to antioxidant function and glucose regulation, glucose, insulin, lipid peroxidation, and advanced oxidation protein products will be observed. Antioxidant capacity will also be measured. as well as completion of weekly questionnaires regarding gut health, and microbiome analysis.
Primary Outcome
A blood sample will be used to characterize the white blood cell population (cell count and distribution)
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT Aloe Vera Extract 1
- DIETARY_SUPPLEMENT Aloe Vera Extract 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2023-03-03 |
| Phase | NA |
What the finished NCT05510050 record still lists
NCT05510050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT05510050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05510050 about?
NCT05510050 is a clinical study titled "Comparison Study of Manapol and DaltonMax on Immune Function, Microbiome, and Related Variables in Men and Women". The present study will compare the effect of Manapol to DaltonMax on select measures of health. Currently, both ingredients are sold both as a stand-alone dietary supplement and as an active ingredient within various multi-nutrient products. Immune function will be assessed using blood samples to d...
What is the current status of trial NCT05510050?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-05-13. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT05510050?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Aloe Vera Extract 1 (DIETARY_SUPPLEMENT), Aloe Vera Extract 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05510050?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05510050's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI